Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute

Professor of Genetics and Medicine, Harvard Medical School

Director, Center for Cancer Genomics, Dana-Farber Cancer Institute

Dana Farber Cancer Institute

617-632-4377

Meyerson Lab

Publications

MYC amplification and MYC protein expression are poor prognostic markers in pediatric and young adult osteosarcoma.

Authors: Authors: Nagy MR, Puopolo O, Alston E, Challa S, Ceca E, Li Y, Cherniack AD, Lazo de la Vega L, Meyerson M, Church AJ, Janeway K.
Cancer 2025-11-15
View full abstract on Pubmed

Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Authors: Authors: Sadagopan A, Carson M, Zamurs EJ, Garaffo N, Chang HJ, Schreiber SL, Meyerson M, Gibson WJ.
Nat Chem Biol 2025-11-12
View full abstract on Pubmed

Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Authors: Authors: Sadagopan A, Carson M, Zamurs EJ, Garaffo N, Chang HJ, Schreiber SL, Meyerson M, Gibson WJ.
Nat Chem Biol 2025-11-03
View full abstract on Pubmed

Germline Variants as Risk Factors for Early-Onset Lung Adenocarcinoma.

Authors: Authors: Yermalovich A, Meyerson M.
J Thorac Oncol 2025-11-01
View full abstract on Pubmed

Lineage rewiring in lung adenocarcinoma via HNF4a and NKX2-1 dynamics.

Authors: Authors: Feng A, Yermalovich A, Meyerson M.
Genes Dev 2025-09-02
View full abstract on Pubmed

Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs).

Authors: Authors: Lee IT, Dohlman A, Gao T, Zhang Z, Kasai Y, Kim GE, Thirlwell C, Nakakura E, Meyerson M, Mäkinen N.
ESMO Gastrointest Oncol 2025-09-01
View full abstract on Pubmed

High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase.

Authors: Authors: Aquilanti E, Barkho S, Bozinov V, Kageler L, Garrity-Janger M, Mesleh MF, Horner S, Ranaghan MJ, Meyerson M.
ACS Chem Biol 2025-07-18
View full abstract on Pubmed

PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration.

Authors: Authors: Ahmad S, Zou T, Hwang J, Zhao L, Wang X, Davydenko A, Buchumenski I, Zhuang P, Fishbein AR, Capcha-Rodriguez D, Orgel A, Levanon EY, Myong S, Chou J, Meyerson M, Hur S.
Nat Commun 2025-04-08
View full abstract on Pubmed

Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma.

Authors: Authors: Pulice JL, Meyerson M.
Mol Cell 2025-04-03
View full abstract on Pubmed

U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations.

Authors: Authors: Walter DM, Cho K, Sivakumar S, Lee IT, Dohlman AB, Shurberg E, Jiang KX, Gupta AA, Frampton GM, Meyerson M.
bioRxiv 2025-03-25
View full abstract on Pubmed